August 8, 2024 (press release) –
dsm-firmenich today announces that it has successfully concluded a new €1.8 billion revolving credit facility (RCF) to replace existing RCF arrangements which expire in 2025: DSM’s €1 billion RCF and Firmenich’s CHF750 million RCF.
The syndicated facility, which dsm-firmenich entered into with a group of 15 banks, has a tenor of five years and two one-year extension options. In addition, the facility is available for general corporate purposes of the Group.
The new RCF is a strong pillar in the Group’s financing strategy. It helps to centralize and streamline dsm-firmenich’s financing structure, and it underpins the group’s financial flexibility. The transaction also confirms the strong relationship dsm-firmenich has with its international and regional financial partners.
For more information:
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. www.dsm-firmenich.com
Disclaimer
This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This communication is not for release, distribution or publication, whether directly or indirectly and whether in whole or in part, into or in the United States of America or any (other) jurisdiction where any of such activities would constitute a violation of the relevant laws of such jurisdiction.
The offer of bonds referred to in this communication was limited in the EEA and the United Kingdom to qualified investors only. The bonds have not been and will not be registered under the US Securities Act of 1933, as amended (the “US Securities Act”) and will also not be registered with any authority competent with respect to securities in any state or other jurisdiction of the United States of America. The bonds may not be offered or sold in the United States of America without either registration of the securities or an exemption from registration under the US Securities Act being applicable.
The English language version of this press release prevails over other language versions.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
